Literature DB >> 33247390

Irreversible Neuronal Damage Begins Just After Aneurysm Rupture in Poor-Grade Subarachnoid Hemorrhage Patients.

Norihito Shimamura1, Toshio Fumoto2, Masato Naraoka2, Takeshi Katagai2, Nozomi Fujiwara2, Kosuke Katayama2, Shouhei Kinoshita2, Keita Yanagiya2, Takao Sasaki2, Akira Kurose3, Hiroki Ohkuma2.   

Abstract

Pathophysiological findings of early brain injury in humans have not permitted conclusive determinations. We explored the essence of this phenomenon by taking intraoperative cortical specimens of Hunt-Kosnik grades IV~V (poor-grade) subarachnoid hemorrhages (SAH). From 2013 to 2017, we treated 39 consecutive poor-grade patients in 226 cases of aneurysmal SAH. Fourteen of the 39 patients agreed to this study following written informed consent. We took specimens from untouched areas prior to surgical intervention: cortex near the ruptured aneurysm for clipping, convexity cortex for cerebral ventricular drainage. Cortical specimens were stained with hematoxylin-eosin, anti-cleaved caspase-3, and anti-DNA/RNA damage staining. Positive signals were calculated in six random, high-power fields for quantitative assessment. Double immunofluorescence was done to evaluate neural damage. Chi-square analyses were carried out to assess the correlation between the Glasgow Outcome Scale at 90 days after the ictus and the number of positive cells. Cortical specimens were taken at 12.7 ± 7.00 h after the first ictus. All 14 cases showed dense nuclei, with the appearance of acidic and shrunken cytoplasms. Diffuse positivity of anti-cleaved caspase-3 and anti-DNA/RNA damage was detected. Cleaved caspase-3 was detected in 68% of neurons, and DNA/RNA damage was detected in 64% of neurons. Positive reactions of both antibodies indicated poor outcome. With poor-grade cases, irreversible ischemic, apoptotic, and oxidative changes were detected in the cerebral cortex within several hours after the ictus. Those changes occurred far from the aneurysm. Our findings suggest that a revolution is needed in the treatment strategy for poor-grade SAH.
© 2020. Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Ischemia; Pathophysiology; Poor-grade; Subarachnoid hemorrhage

Mesh:

Year:  2020        PMID: 33247390     DOI: 10.1007/s12975-020-00875-0

Source DB:  PubMed          Journal:  Transl Stroke Res        ISSN: 1868-4483            Impact factor:   6.829


  14 in total

1.  CEREBRAL PATHOLOGY IN SUBARACHNOID HAEMORRHAGE.

Authors:  B SMITH
Journal:  J Neurol Neurosurg Psychiatry       Date:  1963-12       Impact factor: 10.154

2.  Guidelines for the management of aneurysmal subarachnoid hemorrhage: a guideline for healthcare professionals from the American Heart Association/american Stroke Association.

Authors:  E Sander Connolly; Alejandro A Rabinstein; J Ricardo Carhuapoma; Colin P Derdeyn; Jacques Dion; Randall T Higashida; Brian L Hoh; Catherine J Kirkness; Andrew M Naidech; Christopher S Ogilvy; Aman B Patel; B Gregory Thompson; Paul Vespa
Journal:  Stroke       Date:  2012-05-03       Impact factor: 7.914

Review 3.  Delayed neurological deterioration after subarachnoid haemorrhage.

Authors:  R Loch Macdonald
Journal:  Nat Rev Neurol       Date:  2013-12-10       Impact factor: 42.937

Review 4.  Mechanisms of early brain injury after subarachnoid hemorrhage.

Authors:  Julian Cahill; W Julian Cahill; John W Calvert; John H Calvert; John H Zhang
Journal:  J Cereb Blood Flow Metab       Date:  2006-02-15       Impact factor: 6.200

5.  The critical first minutes after subarachnoid hemorrhage.

Authors:  E Grote; W Hassler
Journal:  Neurosurgery       Date:  1988-04       Impact factor: 4.654

Review 6.  European Stroke Organization guidelines for the management of intracranial aneurysms and subarachnoid haemorrhage.

Authors:  Thorsten Steiner; Seppo Juvela; Andreas Unterberg; Carla Jung; Michael Forsting; Gabriel Rinkel
Journal:  Cerebrovasc Dis       Date:  2013-02-07       Impact factor: 2.762

7.  Analysis of Factors That Influence Long-Term Independent Living for Elderly Subarachnoid Hemorrhage Patients.

Authors:  Norihito Shimamura; Masato Naraoka; Takeshi Katagai; Kosuke Katayama; Kiyohide Kakuta; Naoya Matsuda; Hiroki Ohkuma
Journal:  World Neurosurg       Date:  2016-03-26       Impact factor: 2.104

8.  Signaling pathways for early brain injury after subarachnoid hemorrhage.

Authors:  Gen Kusaka; Mami Ishikawa; Anil Nanda; D Neil Granger; John H Zhang
Journal:  J Cereb Blood Flow Metab       Date:  2004-08       Impact factor: 6.200

9.  Subarachnoid blood acutely induces spreading depolarizations and early cortical infarction.

Authors:  Jed A Hartings; Jonathan York; Christopher P Carroll; Jason M Hinzman; Eric Mahoney; Bryan Krueger; Maren K L Winkler; Sebastian Major; Viktor Horst; Paul Jahnke; Johannes Woitzik; Vasilis Kola; Yifeng Du; Matthew Hagen; Jianxiong Jiang; Jens P Dreier
Journal:  Brain       Date:  2017-10-01       Impact factor: 13.501

10.  Morphological Characteristics of Neuronal Death After Experimental Subarachnoid Hemorrhage in Mice Using Double Immunoenzymatic Technique.

Authors:  Fumi Nakano; Lei Liu; Fumihiro Kawakita; Hideki Kanamaru; Yoshinari Nakatsuka; Hirofumi Nishikawa; Takeshi Okada; Masato Shiba; Hidenori Suzuki
Journal:  J Histochem Cytochem       Date:  2019-09-17       Impact factor: 2.479

View more
  3 in total

Review 1.  The blood-brain barrier and the neurovascular unit in subarachnoid hemorrhage: molecular events and potential treatments.

Authors:  Peter Solár; Alemeh Zamani; Klaudia Lakatosová; Marek Joukal
Journal:  Fluids Barriers CNS       Date:  2022-04-11

2.  Letter to Irreversible Neuronal Damage Begins just After Aneurysm Rupture in Poor-Grade Subarachnoid Hemorrhage Patients.

Authors:  Hidenori Suzuki
Journal:  Transl Stroke Res       Date:  2021-10-13       Impact factor: 6.829

3.  Roles of Rufy3 in experimental subarachnoid hemorrhage-induced early brain injury via accelerating neuronal axon repair and synaptic plasticity.

Authors:  Yang Wang; Jianguo Xu; Wanchun You; Haitao Shen; Xiang Li; Zhengquan Yu; Haiying Li; Gang Chen
Journal:  Mol Brain       Date:  2022-04-23       Impact factor: 4.399

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.